a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Isoxsuprine Injection 5 mg / ml

  • beta adrenoceptor agonist
Category:

Description

Isoxsuprine   is a beta adrenoceptor agonist with selectivity of action for the smooth muscles of the blood vessels, particularly the cerebral vessels and the deeper vessels of the limbs. In higher doses, isoxsuprine has a relaxant action on the smooth muscles of the uterus. Isoxsuprine also has a beneficial effect on blood viscosity. Isoxsuprine  Injection 5 mg / ml is used in treatment of Circulatory disturbances and Uterine hypermotility .Each solution for injection (IM or IV) contains isoxsuprine hydrochloride 10mg/2ml.

3s corporation is Supplier,Exporter ,Wholesaler  for Isoxsuprine  Injection 5 mg / ml in India.

We even  offer contract manufacturing services from WHO GMP approved factories.

Additional Information

Isoxsuprine is contraindicated following recent arterial hemorrhage, in patients with known heart disease, or in severe anemia. It should not be administered parenterally to patients with hypotension, tachycardia, premature detachment of the placenta or immediately postpartum.

Side Effects

Occasional transient palpitations, fall in blood pressure or dizziness have been noted, particularly with parenteral use. These can be controlled by dosage reduction.
A slight increase in the rate of the fetal heart-beat has been noted when isoxsuprine has been given by intravenous infusion in premature labor. Rarely, skin rashes have been associated with its use.

Pack Size